Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Sep 1;180(3):1141-6.
doi: 10.1084/jem.180.3.1141.

Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

Affiliations

Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

M Detmar et al. J Exp Med. .

Abstract

Psoriatic skin is characterized by microvascular hyperpermeability and angioproliferation, but the mechanisms responsible are unknown. We report here that the hyperplastic epidermis of psoriatic skin expresses strikingly increased amounts of vascular permeability factor (VPF; vascular endothelial growth factor), a selective endothelial cell mitogen that enhances microvascular permeability. Moreover, two VPF receptors, kdr and flt-1, are overexpressed by papillary dermal microvascular endothelial cells. Transforming growth factor alpha (TGF-alpha), a cytokine that is also overexpressed in psoriatic epidermis, induced VPF gene expression by cultured epidermal keratinocytes. VPF secreted by TGF-alpha-stimulated keratinocytes was bioactive, as demonstrated by its mitogenic effect on dermal microvascular endothelial cells in vitro. Together, these findings suggest that TGF-alpha regulates VPF expression in psoriasis by an autocrine mechanism, leading to vascular hyperpermeability and angiogenesis. Similar mechanisms may operate in tumors and in healing skin wounds which also commonly express both VPF and TGF-alpha.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1992 Nov 1;176(5):1375-9 - PubMed
    1. Arch Dermatol Res. 1992;284(3):146-9 - PubMed
    1. J Clin Invest. 1993 Jan;91(1):153-9 - PubMed
    1. Cancer Res. 1993 Jun 15;53(12):2912-8 - PubMed
    1. J Clin Invest. 1993 Aug;92(2):671-8 - PubMed

Publication types

MeSH terms

Substances